Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
Nature Medicine2011Vol. 17(3), pp. 366–371
Citations Over TimeTop 1% of 2011 papers
Morgane Rolland, Sodsai Tovanabutra, Allan C. deCamp, Nicole Frahm, Peter B. Gilbert, Eric Sanders‐Buell, Laura Heath, Craig A. Magaret, Meera Bose, Andrea Bradfield, Anne Marie O’Sullivan, Jacqueline Crossler, Teresa M. Jones, Marty Nau, Kim Wong, Hong Zhao, Dana N. Raugi, Stephanie Sorensen, Julia N. Stoddard, Brandon S. Maust, Wenjie Deng, John Hural, Sheri Dubey, Nelson L. Michael, John W. Shiver, Lawrence Corey, Fusheng Li, Steve Self, Jérôme H. Kim, Susan Buchbinder, Danilo R. Casimiro, Michael Robertson, Ann Duerr, M. Juliana McElrath, Francine E. McCutchan, James I. Mullins
Related Papers
- → The changing face of HIV vaccine research(2012)53 cited
- → V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers(2019)34 cited
- → Current views on the potential for development of a HIV vaccine(2017)27 cited
- → HIV-1 Prophylactic Vaccine Trials in Thailand(2005)23 cited
- → Boosting with ALVAC-HIV and AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity(2019)3 cited